The cetuximab saga.
Top Line(s): The decade-long obsession with cetuximab by head and neck (H&N) cancer clinical trialists is puzzling. While the treatment of lung cancer has undergone a molecular renaissance during the same time, H&N cancer trials have essentially tried every possible iteration of cetuximab, chemotherapy, and altered fractionation to no real avail. In 2010, the negative results of RTOG 0129 were a footnote to the realization that patients with HPV-mediated oropharyngeal cancer had remarkably better survival than their HPV-negative counterparts. Granted (at least by some), this superior survival was in the setting of intensive cisplatin-based chemoradiation. A rationale for de-intensifying treatment for these cancers soon came onto the scene, apparently borne from the fact that they respond exceedingly well...to intensified treatment. So, with that reasoning in mind, let’s see how things panned out with De-ESCALaTE and RTOG 1016.
Bottom Line(s): We won't mince words. These are lackluster outcomes following the glimmer of hope offered by initial cetuximab results. But let’s not forget the persistent truth that patients with HPV-driven oropharyngeal cancers do extremely well with our tried and true radiation with concurrent cisplatin. More globally, this should serve as yet another cautionary tale of de-escalating treatment without the due diligence of appropriate phase 3 trials. To end on a positive note, we salute the patients who volunteered for these studies and the investigators who dedicated years to their design, enrollment, and analyses. | Mehanna & Gillison, Lancet 2018
Bottom Line(s): We won't mince words. These are lackluster outcomes following the glimmer of hope offered by initial cetuximab results. But let’s not forget the persistent truth that patients with HPV-driven oropharyngeal cancers do extremely well with our tried and true radiation with concurrent cisplatin. More globally, this should serve as yet another cautionary tale of de-escalating treatment without the due diligence of appropriate phase 3 trials. To end on a positive note, we salute the patients who volunteered for these studies and the investigators who dedicated years to their design, enrollment, and analyses. | Mehanna & Gillison, Lancet 2018
i want to say a very big thanks to Dr Aluya for helping me return my boyfriend home with his powerful spell i never believe my boyfriend will come back to me after Eight months of breaking up with me i decided to go online to search for a powerful spell caster i met a lot of testimony online about Dr Aluya so i decided to give him a try and i contacted him for help and he give me his words not to worry about anything once He is done with his work after 48hrs my boyfriend is going to be back,after 48hrs i receive a phone call when i pick it i hard my boyfriend voice and he started pleading with me to forgive him which i did for more info you can contact his Email aluya.48hoursspelltemple@gmail.com you can also add him up on whatsapp +2348110493039 may God continue to bless your hand work.
ReplyDelete